OraSure Salutes National Black HIV/AIDS Awareness and Information Day with OraQuick Rapid Testing Initiative on February 7th.Business Editors/Health/Medical WritersBETHLEHEM, Pa.--(BUSINESS WIRE)--Feb. 6, 2004 OraSure Partners with HIV Testing Sites Across the Country to Encourage Rapid HIV Testing with OraQuick(R) OraSure Technologies, Inc. (Nasdaq NM:OSUR OSUR Ohio State University Reactor (Columbus, OH) ), the market leader in oral fluid diagnostics, announced today that its OraQuick(R) Rapid HIV-1 Antibody Test will be utilized by numerous locations across the United States to conduct free HIV testing in observance of National Black HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Awareness and Information Day on February 7, 2004. February 7, 2004, is the fourth annual observance of National Black HIV/AIDS Awareness and Information Day. This national mobilization effort is designed to encourage African Americans across the United States and Territorial Areas to get educated, get tested and get involved with HIV/AIDS. OraSure is working with a number of clinics throughout the country and has specifically partnered with the following sites in observance of National Black HIV/AIDS Awareness and Information Day, which will be offering free HIV testing with the OraQuick(R) Rapid HIV-1 Antibody Test: -- Ebony House, Phoenix, Arizona -- Our Common Welfare, Decatur, Georgia -- Matthew 25 AIDS Services, Inc., Henderson, Kentucky -- St. Michael's Medical Center, Newark, New Jersey -- Renaissance III, Dallas, Texas -- Hope Action Care, San Antonio, Texas “San Antonio” redirects here. For other uses, see San Antonio (disambiguation). San Antonio is the second most populous city in Texas, the third most populous metropolitan area in Texas, and is the seventh most populous city in the United States. As of the 2006 U.S. "We are honored to be working with dedicated organizations across the country for National Black HIV/AIDS Awareness and Information Day to help stem the spread of HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. ," said Mike Gausling, Chief Executive Officer of OraSure Technologies. "As the only FDA-approved, CLIA CLIA Clinical Laboratory Improvement Amendments of 1988 Congressional legislation that promulgated quality assurance practices in clinical labs, and required them to measure performance at each step of the testing process from the beginning to the end-point of a (Clinical Laboratory Improvements Amendments of 1988) waived, rapid point-of-care HIV-1 test, we hope OraQuick(R) will help increase the number of people who get tested and learn their HIV results. We will continue to work in partnership with local, state and national agencies to help make this happen." OraQuick(R) is a rapid, point-of-care test designed to detect antibodies to HIV-1 within 20 minutes. OraSure has received FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval for use of the OraQuick(R) device in testing finger-stick and venipuncture venipuncture /veni·punc·ture/ (ven?i-pungk´chur) surgical puncture of a vein. ve·ni·punc·ture or ve·ne·punc·ture n. whole blood specimens for antibodies to HIV-1. In addition, OraSure has received a CLIA waiver for this test, thereby permitting the test to be used in more than 180,000 sites in the United States, such as outreach clinics, community-based organizations and physicians' offices. National Black HIV/AIDS Awareness and Information Day is co-founded and sponsored by Concerned Black Men of Philadelphia, Jackson State University Jackson State University, often abridged as Jackson State or by its initials JSU is a historically black university located in Jackson, Mississippi founded in 1877. - Mississippi Urban Research Center, Health Watch Information and Promotion Service, National Black Alcoholism and Addictions Council, and the National Black Leadership Commission on AIDS. This group is commonly referred to as the Community Capacity Building Coalition, and is currently funded by the Centers for Disease Control and Prevention Centers for Disease Control and Prevention (CDC), agency of the U.S. Public Health Service since 1973, with headquarters in Atlanta; it was established in 1946 as the Communicable Disease Center. ("CDC See Control Data, century date change and Back Orifice. CDC - Control Data Corporation "). More information can be found at www.blackaidsday.org. About OraSure Technologies OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices and tests and other diagnostic products using its proprietary technologies, including immunoassays and other in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. diagnostic tests and other medical devices. These products are sold in the United States and certain foreign countries to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and assays to the life insurance industry and public health markets for the detection of antibodies to HIV-1. In addition, the Company supplies oral-fluid testing solutions for drugs of abuse testing. For more information on the Company, please go to www.orasure.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion